pancreatitis with glp 1 Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk american diabetes association pancreatitis history
Description
Oakland &
The novel incretin agonist, named I-M-150847, promotes robust glucose-stimulated insulin exocytosis in cultured pancreatic beta cells
No subscriptions
These findings highlight the importance of targeted therapeutic strategies based on HF phenotypes
Choosing between Mounjaro and Wegovy
With antiamyloid antibodies Leqembi (lecanemab) and Kisunla (donanemab) now FDAapproved for early Alzheimers, attention is turning to combination strategies that address multiple disease pathways
